Cat que infection: Another virus from China can possibly trigger general health emergency in India:ICMR Kumar Jeetendra | September 28, 2020 At a time when India is still grappling with the novel coronavirus pandemic that started in China’s Wuhan, scientists have warned of another virus from China that has the potential to spread diseases in India. Researchers at the Indian Council of Medical Research (ICMR) have discovered that the’cat que virus’ (CQV), that has infected many …
FDA endorsed drug ‘Teicoplanin’ discovered more powerful in treating COVID – 19 infection: IIT Delhi research Kumar Jeetendra | September 28, 2020 Clinically approved drug”Teicoplanin” is a potential therapeutic alternative against COVID-19 and may be ten times more effective than many drugs being currently used, a study by Indian Institute of Technology (IIT), Delhi has found. The research from the institute’s Kusuma School of Biological Science screened an assemblage of 23 approved drugs, which have shown leads …
Novel neuroimaging investigation on dissociative side effects uncovers wounds of youth Trauma Kumar Jeetendra | September 27, 2020 Trauma can cause dissociative side effect in individuals -, for example, encountering amnesia, an out-of-body understanding, feeling genuinely numb – which may help individuals adapt. Experiencing these symptoms intensely or for a long time, however, can negatively impact an individual’s ability to function. A group drove by examiners at McLean Hospital has now discovered that …
Translational exploration preparing program causes understudies to more readily comprehend patients’ issues Kumar Jeetendra | September 27, 2020 Translational research aims to speed research breakthroughs into the practice. And yet, training for basic scientists and clinicians too often remains siloed, resulting in divergent cultures and a lack of chance for cross-disciplinary collaboration. The South Carolina Clinical & Translational Research (SCTR) Institute’s TL1 application, a translational research training program for doctoral students in the …
Yale assigns three free research facilities to perform SalivaDirect COVID-19 test Kumar Jeetendra | September 26, 2020 Laboratory evaluations of surgical and N95 masks by researchers at the University of California, Davis, show that they do cut down the amount of aerosolized particles generated during breathing, coughing and talking. Tests of homemade fabric face coverings, however, show that the fabric itself releases a large amount of fibers to the air, underscoring the …
New analytic instrument may permit on-the-spot recognition of Covid disease Kumar Jeetendra | September 25, 2020 Scientists at the University of Warwick have demonstrated a possible diagnostic tool for detecting Covid-19 using sugars will operate with a virus as opposed to just its proteins, a significant step in making it a viable evaluation in future. Coronavirus diagnostics currently require centralized facilities and collection/distribution of swabs and outcomes are’next day’. A new …
Iran, Russia talking about joint creation of COVID-19 immunization Kumar Jeetendra | September 25, 2020 Iran and Russia’s sovereign wealth finance RDIF are discussing the joint creation of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. “We are holding discussions, I talked with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that …
AstraZeneca gets halfway invulnerability in ease EU antibody bargain Kumar Jeetendra | September 25, 2020 European authorities will pay claims over an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official told Reuters. The deals reflect different approaches by two of the world’s best drugmakers for protecting themselves as a debate rages about liabilities for vaccines …
New T-cell-based immunization procedure gives more extensive insurance against occasional flu Kumar Jeetendra | September 24, 2020 As Americans begin pulling their sleeves up for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternate vaccine approach that provides wider protection against seasonal flu. In a study published in Cell Reports Medicine today (Sept. 22), scientists describe a T-cell-based vaccine strategy that’s effective against multiple …
Molecular investigation of COVID-19’s subsequent wave shows freak infections connected to quick spread Kumar Jeetendra | September 24, 2020 Molecular analysis of COVID-19’s powerful second wave in Houston — from May 12 to July 7 — shows that a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085 COVID-positive patients analyzed at Houston Methodist since early March show a …
‘Quiet’ influx of neurological results might be on its way due to COVID-19 Kumar Jeetendra | September 23, 2020 Is the world ready a tide of neurological consequences which might be on its way as a result of COVID-19? A group of neuroscientists and clinicians are examining the potential link between COVID-19 and increased risk of Parkinson’s disease, and measures to get ahead of the curve. In a review paper published today, researchers put …
Mumbai’s KEM Hospital begins preliminaries of Covishield immunization Kumar Jeetendra | September 23, 2020 Bharat Biotech Place to Create intranasal COVID-19 vaccine: This is all you need to know Hyderabad-based Bharat Biotech announced on September 23 that it has collaborated with the Washington University School of Medicine to develop an intranasal COVID-19 vaccine. Here are seven things you need to know about the novel chimp-adenovirus vaccine candidate: Bharat Biotech …